Annals of Emergency Medicine
Volume 48, Issue 5 , Pages 594-595 , November 2006

Commentary

References 

  1. Lednicky JA. Hantaviruses: a short review. Arch Pathol Lab Med. 2003;127:30–35
  2. Centers for Disease Control and Prevention. Hantavirus pulmonary syndrome: United States: updated recommendations for risk reduction. MMWR Morb Mortal Wkly Rep. 2002;51:1–12
  3. Peters CJ, Khan AS. Hantavirus pulmonary syndrome: the new American hemorrhagic fever. Clin Infect Dis. 2002;34:1224–1231
  4. Maes P, Clement J, Gavrilovskaya I, et al. Hantaviruses: immunology, treatment and prevention. Viral Immunol. 2004;17:481–497
  5. Chapman LE, Mertz GJ, Peters CJ, et al. Intravenous ribavirin for Hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience: Ribavirin Study Group. Antivir Ther. 1999;4:211–219

PII: S0196-0644(06)02268-2

doi: 10.1016/j.annemergmed.2006.09.013

Annals of Emergency Medicine
Volume 48, Issue 5 , Pages 594-595 , November 2006

Article Tools